INOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Provided By PR Newswire
Last update: Aug 12, 2025
PLYMOUTH MEETING, Pa., Aug. 12, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced its financial results for the second quarter of 2025 and provided an update on recent company developments.
Read more at prnewswire.com
